机译:急性髓性白血病,具有T(3; 21)(Q26.2; Q22)在黄色样蛋白关节炎的低剂量甲氨蝶呤治疗后开发,表达两种AML1 / MDS1 / EVI1融合蛋白:案例报告
Tokyo Med &
Dent Univ Grad Sch Med &
Dent Sci Dept Hematol Tokyo 1138510 Japan;
Tokyo Med &
Dent Univ Grad Sch Med &
Dent Sci Dept Hematol Tokyo 1138510 Japan;
Tokyo Med &
Dent Univ Grad Sch Med &
Dent Sci Dept Hematol Tokyo 1138510 Japan;
Tokyo Med &
Dent Univ Grad Sch Med &
Dent Sci Dept Hematol Tokyo 1138510 Japan;
Tokyo Med &
Dent Univ Grad Sch Med &
Dent Sci Dept Hematol Tokyo 1138510 Japan;
Tokyo Med &
Dent Univ Grad Sch Med &
Dent Sci Dept Hematol Tokyo 1138510 Japan;
Tokyo Med &
Dent Univ Grad Sch Med &
Dent Sci Dept Hematol Tokyo 1138510 Japan;
acute myeloid leukemia; myelodysplastic syndrome; therapy-related myeloid neoplasms; t(3; 21)(q26.2; q22); runt related transcription factor 1; ecotropic virus integration site 1 protein homolog; methotrexate; rheumatoid arthritis;
机译:急性髓性白血病,具有T(3; 21)(Q26.2; Q22)在黄色样蛋白关节炎的低剂量甲氨蝶呤治疗后开发,表达两种AML1 / MDS1 / EVI1融合蛋白:案例报告
机译:人AML1 / MDS1 / EVI1融合蛋白在小鼠中诱发急性骨髓性白血病(AML):人AML的模型
机译:AML1和EVI1致癌成分都是AML1 | MDS1 | MDS1 | [溶胶]的合作所必需的,BCR | [溶胶] | ABL在急性髓性白血病诱导小鼠中
机译:小剂量甲氨蝶呤治疗类风湿性关节炎并表达两种AML1 / MDS1 / EVI1融合蛋白后发生的t(3; 21)(q26.2; q22)急性髓细胞白血病:病例报告
机译:MDS1 / EVI1增强了TGF-β1信号传导,并强化其生长抑制作用,但白血病相关融合蛋白AML1 / MDS1 / EVI1,T(3; 21)的产物,响应于TGF-β1而缺乏生长抑制